SFN and metastatic malignant neoplasm in the lymph nodes: In esophageal squamous cell carcinoma (OSCC), downregulation of SFN has been shown to be associated with β-catenin expression, proliferation, invasion depth, lymph node metastasis and has been shown to have potential as a prognostic biomarker for OSCC [33,34,35].